Loading…
Preparing for the Next Pandemic Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Preparing for the Next Pandemic Act This bill provides funding to the Biomedical Advanced Research and Development Authority (BARDA) for activities to expand domestic manufacturing of medical countermeasures and to the Office of the Assistant Secretary for Preparedness and Response for grants to establish state stockpiles of medical supplies for use during public health emergencies. These funds are designated as an emergency requirement, which exempts them from discretionary spending limits and other budget enforcement rules. The bill also makes other changes to BARDA's authorities and duties with respect to countermeasures and the administration of the Strategic National Stockpile.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4267-4270)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2021 · fourth_quarter · Disaster Planning/Emergencies
S.4231 - Preparing for the Next Pandemic Act. Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Health Issues
S.4231 - Preparing for the Next Pandemic Act HR 3263 Outreach - DHS Medical Countermeasures Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Homeland Security
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Budget/Appropriations
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · third_quarter · Budget/Appropriations
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · third_quarter · Homeland Security
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · third_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · third_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2021 · third_quarter · Disaster Planning/Emergencies
S.4231 - Preparing for the Next Pandemic Act. Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: Office of Administration, White House Office
2021 · third_quarter · Health Issues
S.4231 - Preparing for the Next Pandemic Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to chemical and biological defense and access to Naloxone; H.R. 4502 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Disaster Planning/Emergencies
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to chemical and biological defense and access to Naloxone; H.R. 4502 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Budget/Appropriations
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to chemical and biological defense and access to Naloxone; H.R. 4502 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Homeland Security
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to chemical and biological defense and access to Naloxone; H.R. 4502 - Department of Labor, Health and Human Services, and Education, and related agencies, appropriations Act, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
H.R.4350/S.2792 - National Defense Authorization Act for Fiscal Year 2022, provisions related to biological and chemical defense and access to naloxone; S. 4231 (116th Congress) - Preparing for the Next Pandemic Act; Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2021 · second_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Budget/Appropriations
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Homeland Security
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Disaster Planning/Emergencies
S.4231 - Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · second_quarter · Budget/Appropriations
H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Homeland Security
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Disaster Planning/Emergencies
Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Program Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Department of Labor, Health and Human Services, and Education, and related agencies, appropriations bill, 2022 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Budget/Appropriations
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: $630,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · second_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: $630,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · second_quarter · Homeland Security
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: $630,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · second_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Client expense: $630,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · second_quarter · Health Issues
S.4231 - Preparing for the Next Pandemic Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
National Defense Authorization Act (NDAA) for FY22, provisions related to biological and chemical defense and access to naloxone; S. 4231 (116th Congress) - Preparing for the Next Pandemic Act; Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2021 · first_quarter · Budget/Appropriations
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Homeland Security
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Budget/Appropriations
H.R. 1319 - American Rescue Plan Act of 2021 - Title II, Subtitle H - provisions authorizing grants to states and community entities to address drug misuse during COVID-19, including Naloxone access; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Fiscal Year 22 Appropriations funding for Department of Health and Human Services - proposals for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
H.R. 1319 - American Rescue Plan Act of 2021 - Title II, Subtitle H - provisions authorizing grants to states and community entities to address drug misuse during COVID-19, including Naloxone access; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Fiscal Year 22 Appropriations funding for Department of Health and Human Services - proposals for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Homeland Security
H.R. 1319 - American Rescue Plan Act of 2021 - Title II, Subtitle H - provisions authorizing grants to states and community entities to address drug misuse during COVID-19, including Naloxone access; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Fiscal Year 22 Appropriations funding for Department of Health and Human Services - proposals for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Disaster Planning/Emergencies
H.R. 1319 - American Rescue Plan Act of 2021 - Title II, Subtitle H - provisions authorizing grants to states and community entities to address drug misuse during COVID-19, including Naloxone access; H.R. 706 and S. 166 - Emergency Support for Substance Use Disorders Act - bills authorizing grants to states and community-based entities to address substance use during COVID-19, including Naloxone distribution for opioid overdose; Draft legislation to reauthorize and expand grant programs for State responses to the opioid use disorder crisis; Draft reauthorization of Comprehensive Addiction and Recovery Act (CARA) expanding access to treatments and recovery programs for addiction, including opioid use; S.4231 - Preparing for the Next Pandemic Act (116th Congress) - provisions for vaccines, treatment, and testing capacity, improvements to Strategic National Stockpile, and public private partnerships for public health emergencies; Draft Fiscal Year 22 National Defense Authorization bill - provisions related to chemical and biological defense and access to Naloxone; Draft Fiscal Year 22 Appropriations funding for Department of Health and Human Services - proposals for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Disaster Planning/Emergencies
S.4231 - Preparing for the Next Pandemic Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · first_quarter · Health Issues
National Defense Authorization Act (NDAA) for FY22, provisions related to biological and chemical defense and access to naloxone; S. 4231 (116th Congress) - Preparing for the Next Pandemic Act; Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2021 · first_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: $1,470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · first_quarter · Homeland Security
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: $1,470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · first_quarter · Health Issues
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: $1,470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · first_quarter · Budget/Appropriations
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Client expense: $1,470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2021 · first_quarter · Health Issues
S.4231 - Preparing for the Next Pandemic Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Homeland Security
S. 4231 - Preparing for the Next Pandemic Act. H.R. 8406 - The Heroes Act. HEALS Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Budget/Appropriations
Legislative and Administrative monitoring and outreach on issues related to state stockpiling needs. Legislative and Administrative monitoring and outreach on issues related to the COVID-19 relief funding. Legislative outreach on issues related to the implementation of H.R. 748, CARES Act (P.L. 116-136). Monitoring and outreach on legislative activity related to the HEALS Act (S. 4317 - S. 4324). H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES) Act. S. 4231, Preparing for the Next Pandemic Act. S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 116-260).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Disaster Planning/Emergencies
Legislative and Administrative monitoring and outreach on issues related to state stockpiling needs. Legislative and Administrative monitoring and outreach on issues related to the COVID-19 relief funding. Legislative outreach on issues related to the implementation of H.R. 748, CARES Act (P.L. 116-136). Monitoring and outreach on legislative activity related to the HEALS Act (S. 4317 - S. 4324). H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES) Act. S. 4231, Preparing for the Next Pandemic Act. S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 116-260).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Legislative and Administrative monitoring and outreach on issues related to state stockpiling needs. Legislative and Administrative monitoring and outreach on issues related to the COVID-19 relief funding. Legislative outreach on issues related to the implementation of H.R. 748, CARES Act (P.L. 116-136). Monitoring and outreach on legislative activity related to the HEALS Act (S. 4317 - S. 4324). H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES) Act. S. 4231, Preparing for the Next Pandemic Act. S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 116-260).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE